Aaron Vaccaro
Viome Life Sciences raises $67M Series C to expand at-home gut, immune and cancer screening tests
Bellevue-based Viome Life Sciences raised over $67 million in Series C funding to expand its at-home health screening test business, bringing total capital raised to more than $150 million. Founder and CEO Naveen Jain said the company plans to grow headcount from about 150 to ~200 and will hire more scientists, researchers, and engineers while keeping lab and supplement manufacturing automated.
Tagboard Raises $2.3M Secondary for Series A to Reach $10.3M; West River Group, Spivy Private Capital and Sports Loft Join Investors; Anthony Bontrager Named to Board
Tagboard announced a $2.3 million secondary closing for its Series A, bringing the round to $10.3 million and adding West River Group, Spivy Private Capital and Sports Loft as investors while Anthony Bontrager joins the board. The cloud production platform says it serves over 600 media brands, powered 20 million stories last year, and highlights recent use in major 2022 broadcasts like the Super Bowl and Olympics.
Viome raises $54M to develop saliva-based cancer diagnostics and expand microbiome consumer business
Viome Life Sciences raised $54 million to advance cancer diagnostics and support its consumer microbiome testing and customized supplement business, bringing total funding to over $125 million while targeting $100M revenue and one million customers next year.
Anthony Bontrager of WestRiver Group says he makes 3–5 PNW SaaS/AI investments yearly with $500k–$5M initial checks and $10M follow-on capacity
Anthony Bontrager, a former adtech founder and current investor at WestRiver Group, favors hands-on board involvement and invests in PNW SaaS/AI/ML companies with initial checks of $500k–$5M, targeting 3–5 new deals yearly and about 15–20 monthly pitches. He highlights Qorus Software as a standout portfolio company and emphasizes governance, go-to-market support, and follow-on reserves of ~$10M per company.
